ABSI compared with PRME: revenue, margins and what each company keeps, and the suppliers and customers both name

ABSIAbsci Corp

Mkt capRevenueRevenue

PRMEPrime Medicine, Inc.

Mkt capRevenueRevenue

Compare

ABSIAbsci Corp

PRMEPrime Medicine, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

ABSIwithPRME

×0.41co-movement · PRME on ABSI · 499d

r 0.42scale to r 0.75

Shared co-movers4with ABSIwith PRME

RXRXRecursion Pharmaceuticals, Inc.r 0.58r 0.57

CRSPCRISPR Therapeutics AGr 0.55r 0.61

BEAMBeam Therapeutics Inc.r 0.50r 0.60

SDGRSchrodinger, Inc.r 0.49r 0.41

ABSI, solidPRME, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ABSIAbsci Corp

11.12▼−8.10%· post 11.21

Mkt cap$1.9BRevenue$650,000Q4 FY25Revenue$3MFY25

PRMEPrime Medicine, Inc.

4.72▼−9.92%· post 4.71

ClosedOct 30 '26

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

Compare

ClosedOct 30 '26

ABSIAbsci Corp

PRMEPrime Medicine, Inc.

11.12▼−8.10%post 11.21

Price

4.72▼−9.92%post 4.71

$1.9B

Mkt cap

—

Q4 FY25$650,000

Revenue

$1MQ2 FY26

FY25$3M

Revenue

$5MFY25

ABSI11.12▼−8.10%vsPRME4.72▼−9.92%ClosedOct 30 '26